Recalibrating Pharma after the GST Overhaul
The reform creates an opportunity for the pharma and medical device industry to advance affordable care, expand access to medicines and diagnostics, and improve insurance coverage.
ITC Tracking Mechanisms | 15/09/2025
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy